1. Home
  2. REBN vs VIRX Comparison

REBN vs VIRX Comparison

Compare REBN & VIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REBN
  • VIRX
  • Stock Information
  • Founded
  • REBN 2015
  • VIRX 2007
  • Country
  • REBN United States
  • VIRX United States
  • Employees
  • REBN N/A
  • VIRX N/A
  • Industry
  • REBN Restaurants
  • VIRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • REBN Consumer Discretionary
  • VIRX Health Care
  • Exchange
  • REBN Nasdaq
  • VIRX Nasdaq
  • Market Cap
  • REBN 8.6M
  • VIRX 9.9M
  • IPO Year
  • REBN 2022
  • VIRX N/A
  • Fundamental
  • Price
  • REBN $1.80
  • VIRX $0.16
  • Analyst Decision
  • REBN
  • VIRX Buy
  • Analyst Count
  • REBN 0
  • VIRX 4
  • Target Price
  • REBN N/A
  • VIRX $5.00
  • AVG Volume (30 Days)
  • REBN 107.6K
  • VIRX 4.4M
  • Earning Date
  • REBN 11-19-2024
  • VIRX 11-13-2024
  • Dividend Yield
  • REBN N/A
  • VIRX N/A
  • EPS Growth
  • REBN N/A
  • VIRX N/A
  • EPS
  • REBN N/A
  • VIRX N/A
  • Revenue
  • REBN $5,502,528.00
  • VIRX N/A
  • Revenue This Year
  • REBN $185.18
  • VIRX N/A
  • Revenue Next Year
  • REBN $64.55
  • VIRX N/A
  • P/E Ratio
  • REBN N/A
  • VIRX N/A
  • Revenue Growth
  • REBN 9.70
  • VIRX N/A
  • 52 Week Low
  • REBN $0.92
  • VIRX $0.13
  • 52 Week High
  • REBN $8.80
  • VIRX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • REBN 64.22
  • VIRX 40.60
  • Support Level
  • REBN $1.06
  • VIRX $0.20
  • Resistance Level
  • REBN $1.97
  • VIRX $0.26
  • Average True Range (ATR)
  • REBN 0.19
  • VIRX 0.03
  • MACD
  • REBN 0.09
  • VIRX 0.00
  • Stochastic Oscillator
  • REBN 81.32
  • VIRX 16.67

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Share on Social Networks: